MARKET

RMTI

RMTI

Rockwell Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.220
-0.040
-1.77%
After Hours: 2.220 0 0.00% 16:00 12/13 EST
OPEN
2.250
PREV CLOSE
2.260
HIGH
2.290
LOW
2.190
VOLUME
231.72K
TURNOVER
--
52 WEEK HIGH
6.88
52 WEEK LOW
1.810
MARKET CAP
141.83M
P/E (TTM)
-3.6086
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RMTI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RMTI News

  • When Will Rockwell Medical, Inc. (NASDAQ:RMTI) Become Profitable?
  • Simply Wall St..3d ago
  • V&M Premium Portfolio: 2019 End Of Year Report Card Through Week 49
  • Seeking Alpha - Article.5d ago
  • FDA Says Rockwell Medical Webpage Triferic 'False Or Misleading'
  • Bloomberg.11/25 20:04
  • Rockwell Medical, Inc. to Present at 31st Annual Piper Jaffray Healthcare Conference
  • GlobeNewswire.11/21 11:50

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company. The Company is targeting end-stage renal disease and chronic kidney disease with products for the treatment of iron deficiency and hemodialysis. The Company is also a manufacturer of hemodialysis concentrates for dialysis providers and distributors. The Company’s renal drug therapy, Triferic, supports disease management initiatives. Triferic is therapy indicated to replace iron and maintain hemoglobin in hemodialysis patients via dialysate during each dialysis treatment. The Company has developed multiple formulations of Triferic: Dialysate Triferic and Intravenous Triferic (I.V. Triferic). Dialysate Triferic is the therapeutic indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients.
More

Webull offers Rockwell Medical Inc (RMTI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.